Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

Cancer letters - 8 Nov 2001

Ko Y H, Pedersen P L, Geschwind J F

Abstract excerpt

The rabbit VX2 tumor when implanted in the liver has proven convenient as a model for studying hepatocellular carcinomas. However, its metabolic properties have not been well studied. Significantly, studies described here show that the VX2 tumor exhibits a high glycolytic/high hexokinase phenotype that is retained following implantation and growth in rabbit liver. In addition, results of a limited screen show...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites
Share to Deoxyglucose
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycolysis

Share to Hexokinase

Share to Lactic Acid

Share to Liver Neoplasms, Experimental

Share to Pyruvates

Source

Identifiers

PMID: 11578813
DOI: 10.1016/s0304-3835(01)00667-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.PMID 11578813Read ↗

Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.Semantic proximity Read ↗

Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase.Semantic proximity Read ↗

The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expressionSemantic proximity Read ↗

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.Semantic proximity Read ↗

Aerobic glycolysis supports hepatitis B virus biosynthesis through interaction between viral surface antigen and pyruvate kinase isoform M2Semantic proximity Read ↗

Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-BromopyruvateSemantic proximity Read ↗

Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.Semantic proximity Read ↗

Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.Semantic proximity Read ↗

Clinical Effect of the Warburg Effect in Stage IV Hepatocellular CarcinomaSemantic proximity Read ↗

Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.